Patient Reported Outcomes with JAKi’s in Rheumatoid & Psoratic Arthritis
Time: 3:05 pm
day: Day One
Details:
- Detailing how PROs are an important clinical endpoint for patients
- Presenting the results of JAKi therapy in RA across DMARD-IR, bDMARDIR and DMARD-naive RA patients; how they correspond w/ clinical endpoints
- Detailing how these results are clinically meaningful and help patients feel and function as if they no longer have arthritis
